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Available online 3 August 2016Background: Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) has been rec-
ommended to distinguish Tako-tsubo cardiomyopathy (TTC) from either acutemyocardial infarction or myocar-
ditis.
Method: 44 consecutive patientswith conﬁrmedMayoClinic criteria for TTC underwent CMR imaging at 1.5 Tesla
during the acute phase. 10 patients who had CMRI to exclude scar related ventricular tachycardia, and had neg-
ative studies, were used as negative controls. LGE was quantitated at two signal intensity thresholds (CircleCVi
software) at N2 and N5 standard-deviations (SD) above reference myocardium, and compared to biomarkers.
Findings:Mean door-to-CMR timewas 57 hours. 18 patients (41%) had LGE N2 SD localized to the area of abnor-
mal wall motion, representing 28.9± 11.2% LVmass. In 16 of these 18 patients (89%) LGE signal intensity was N5
SD above normalmyocardium, representing 12.1± 10% LVmass. LGE signal intensitywas signiﬁcantly greater in
TTC than in matched controls (p b 0.05) but lower than in STEMI patients (p b 0.05). Mean troponin was signif-
icantly higher in LGE positive patients (2.5±1.8 vs 4.4±6.9, p=0.001).Mean ejection fraction (EF) by CMRwas
45% ± 8.7 in LGE-negative, and 40% ± 7.1 in LGE-positive patients (p = 0.37). Recovery of segmental function
was conﬁrmed at follow-up, mean EF was 59% in both groups.
Conclusion: LGE was present in 41% of cases of TTC, 89% of which had intense enhancement N5 SD above normal
myocardium. Presence of LGE was associated with worse myocardial injury in the acute setting, with no differ-
ence in recovery of function.
Crown Copyright © 2016 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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The “Tako-tsubo” cardiomyopathy (TTC), also known as apical bal-
looning syndrome or stress cardiomyopathy [1], is an emerging clinical
syndrome presenting with acute chest pain or dyspnoea, associated
with new ST-T segment abnormalities, regional transient myocardial
dysfunction, typically localized at left ventricular (LV) apex and usually
extended beyond a single vessel territory, serum cardiac enzyme release
and absence of signiﬁcant coronary lesions at coronary angiography [2].
Among patients presenting with clinically suspected acute coronary
syndrome (ACS), its prevalence is reported to range between 1.2%–
2.0% and it occurs almost exclusively in postmenopausal women,rince CharlesHospital, Brisbane,
on-Craig).
Ireland Ltd. This is an open access artbeing often, but not exclusively, associated with emotional or physical
stress [3,4]. Tako-tsubo cardiomyopathy now accounts for up to 1% of
admissions for suspected myocardial infarction in Japan, and is increas-
ingly recognised in the West owing to primary coronary intervention,
accounting for up to 1 in 30 cases of primary angioplasty [5,6]. The pat-
tern of left ventricular dysfunction has been labelled in Japanese as
“Tako-tsubo” cardiomyopathy due to its resemblance to the traditional
Japanese octopus-pot [7], and elsewhere in the world has also been
termed “transient left ventricular apical ballooning” and “stress cardio-
myopathy” [1,8]. Cardiac MRI has been used to evaluate myocardial
viability and all patients had coronary angiography to rule out ath-
erosclerotic CAD as a substrate for the ventricular dysfunction [8].
Given that positive serum troponin and oedema occur in patients
with Tako-tsubo cardiomyopathy, we hypothesised that Late Gado-
linium Enhancement (LGE) may be detected by CMR when per-
formed in the acute phase, and LGE has been reported in TTC casesicle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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manner [9,10].
2. Method
44 consecutive patients with conﬁrmed clinical, ECG, angiographic
and left ventriculographic ﬁndings of TTC using the Mayo Clinic criteria
were prospectively enrolled in the study at the time of initial
hospitilisation [11] [Fig. 1]. All patients underwent invasive coronary
angiography, conﬁrming the absence of signiﬁcant epicardial coronary
artery stenosis with presence of wall motion defect at ventriculography
(either ‘typical’ apical ballooning, or ballooning of the mid-segments of
the anterior wall, referred to as ‘mid-wall variant’). In all patients
screening for pheochromocytoma was performed with both serum
and urine metanephrines [12].
CMR was performed in the acute phase as soon as the patient was
clinically stable, using a 1.5 Tesla system (Signa Twinspeed, GE
Healthcare, Milwaukee, WI, USA) with an 8-element cardiac phased
array coil. Steady state free precession (SSFP) images were acquired in
multiple planes using the following protocol: TE 1.5 ms, TR 3.4 ms, ﬂip
angle 45, receiver bandwidth ±125 kHz, FOV 35 cm, slice thickness
8 mm, slice gap 2 mm, acquisition matrix 224 × 224, number of aver-
ages = 1, ECG gating, k-space segmentation 16 views per segment.
Twenty cardiac phases per slice were reconstructed. T2-weighted
(T2w) oedema imagingwas performed in the same short axis slice loca-
tions using a fat-suppressed double inversion recovery sequence.
Late gadolinium enhancement (LGE) imaging was performed in the
same slice locations as SSFP images, at 10 and 20 min following intrave-
nous administration of 0.2 mmol/kg of gadolinium-DTPA using a seg-
mented inversion recovery fast gradient echo sequence with theFig. 1. Patient with normal coronary arteries (A), and the classic takotsubo “apical balloonin
showing the apical ballooning on cine imaging (C), with quantitative LGE represented by an A
N5 SD above remote myocardium, most obvious in the apical slice (G).following parameters: TE 2.8 ms, TR 6 ms, TI 170–250 ms (depending
on time elapsed since injection), ﬂip angle 20, receiver bandwidth
±31 kHz, FOV 35 cm, slice thickness 8 mm, slice gap 2 mm, acquisition
matrix 256 × 160, number of averages= 2, ECG gating with k-space seg-
mentation of 24 views per segment. All images were acquired at end ex-
piration using respiratory bellows to conﬁrm compliance with breathing
instructions. Measures of ventricular function were derived with MASS
software (MEDis Medical Imaging Systems, Leiden, NL) on an Advantage
Windows workstation (GE Healthcare, Milwaukee, WI, USA). In cases
where quantitative assessment of the right ventricle was required, imag-
ing was performed using the modiﬁed RV short axis series [13].
Quantiﬁcation of late gadolinium enhancement was assessed as rec-
ommended by the International Consensus Group on Cardiovascular
Magnetic Resonance inMyocarditis [14,15]. Using a crossplane localizer,
the regions of LGE were cross-referenced to the corresponding areas of
hypokinesis on SSFP images, and visually analysed for presence of in-
creased signal intensity of LGE images. LGE was quantitated using the
cvi42 software (v4.1.5, Circle Cardiovascular Imaging, Calgary, Canada).
Endocardial and epicardial contours were manually drawn in the short
axis and two long axis frames with careful reference to SSFP images. A
region-of-interest (ROI) was drawn in an area of reference normalmyo-
cardium having normal wall motion and no edema on T2 images. Signal
thresholds of both N2 SD and N5 SD above the reference myocardium
were applied, with an automated signal detection algorithm to identify
areas of abnormal myocardium (Figs. 1, 2). Extent of LGE was normal-
ized to LV mass for each case, and expressed as a percentage (LGE%)
(see Fig. 3).
When available, echocardiography with 2D speckle tracking for
global longitudinal strain was performed during the acute admission,
using a GE E9 system and quantitation with Echo-PAC software (Fig. 2).g” wall motion abnormality at ventriculography (B). CMR end-systolic 4-chamber view
HA16-segment model polar plot (D). E-G show the signal analysis contours, with signal
Fig. 2. TTCwithout LGE. Upper: CMR LGE images in 2-chamber and 4-chamber views, showing absence of late gadolinium enhancement. Lower: Quantitative analysis of 2D speckle strain
(panel A) and late gadolinium enhancement (panel B) demonstrated in matching segmental polar maps (AHA segments).
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tachycardia, with normal CMR scans and no LGE were used as negative
controls. A cohort of 10 patients post-ST Elevation myocardial infarc-
tion (STEMI) were used as positive controls, and signal ratios of in-
farcted myocardium to normalized (non-infarct related) myocardium
were measured using cvi42 software. All controls were scanned with
an identical protocol and LGE was quantitatively assessed using the
same method.
2.1. Statistics
Categorical variables are expressed as number and percentage of pa-
tients. Continuous data are estimated asmean (SD) or asmedian. Differ-
ences between groups were assessed using the 2-tailed Fisher exact
test. Statistical tests were performed using Medcalc and GraphPad
Prism (V6.0, LaJolla, CA). The presence of LGE, LGE% and change in left
ventricular ejection fraction (LVEF) at follow up were compared using
a Student's t-test. Statistically signiﬁcant changes were designated to
occur with a 2-sided p value of b0.05.
3. Results
The mean age of patients with TTC was 66 years (range 41–
87 years), 91% percent female, of which 90% were post-menopausal
(Table 1).
Identiﬁable precipitating events were recorded in 82%; such events
included newdiagnoses ofmalignancy, orthopaedic trauma, attendance
at daughter's funeral, medical illness (diverticulitis, pneumonia), andtwo cases of emotive discussions. In 18% events were not recorded al-
though it is recognised that a proportion of patients with TTC may not
have a clearly identiﬁable precipitating event [1]. One female patient,
who presentedwith pericardial tamponade (due tomalignant effusion)
and normal wall motion on baseline echocardiography, developed TTC
acutely after pericardiocentesis, which is a previously unreported pre-
cipitating event. One patient had signiﬁcant left ventricular outﬂow
tract obstruction, with systolic anterior motion of the mitral valve.
Screening for pheochromocytoma revealed no abnormal results in this
cohort.
Cardiac magnetic resonance was performed in the acute phase with
a mean door-to-CMR time of 57 h.Wall motion defects were present in
all cases; the typical “apical ballooning”wall motion defect was present
in 28 cases, and a midwall variant in 16 cases (Table 1). There was no
signiﬁcant difference in LVEF between these two groups (mean 40% vs
44% respectively, p = NS). 18 patients (41%) had LGE N2 SD localized
to the area of abnormal wall motion, representing 28.9 ± 11.2% LV
mass. In 16 of these 18 patients (89%) LGE was N5 SD above normal
myocardium, representing 12.1 ± 10% LV mass. LGE signal intensity of
N5 SD in this condition has not been previously described. The pattern
of LGE differed to that seen in both ischemia and myocarditis, in that
it involved the full thickness of the affected myocardium in a diffuse
manner, rather than the sub-endocardial high signal present in ischae-
mic injury, or the sub-epicardial layers typically seen in myocarditis.
Of interest, the patient with resuscitated sudden cardiac death also ex-
hibited right ventricular involvement manifest by dyskinesia in the
mid-segments of the right ventricular free wall, which recovered on
subsequent imaging. Mean ejection fraction (EF) by CMR was 45% ±
Fig. 3. TTC with LGE: Upper: 4chamber view showing increased signal intensity in the septum and apical segments (panel A, arrows), and quantitative signal intensity analysis with
automated colour overlay (panel B) showing N2 standard deviations above normal reference myocardium in the unaffected segments. Lower: Polar maps of 2D speckle strain (panel
A) and LGE-CMR (panel B) demonstrating concordance between the segments with markedly abnormal strain and the degree of enhancement by CMR.
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Recovery of segmental function was conﬁrmed at follow-up, mean EF
was 59% in both groups.
Mean troponin was signiﬁcantly higher in LGE positive patients
(2.5 ± 1.8 vs 4.4 ± 6.9, p = 0.001) [Fig. 4] Mean ejection fraction (EF)
by CMR was 45% ± 8.7 in LGE-negative, and 40% ± 7.1 in LGE-positive
patients (p = 0.37) [Fig. 5]. All patients experienced full recovery of
function at follow-up (**p b 0.01).
LGE positive patients had a higher serum peak troponin-I in the
acute phase (2.5 ± 1.8 vs 4.4 ± 6.9, p = 0.001) [Fig. 4]. Of note,
LGE signal intensity in TTC patients was signiﬁcantly greater than
in controls (p b 0.05) but signiﬁcantly lower than in STEMI patients
(p b 0.05).
At 6 months follow-up all patients had full resolution of left ventric-
ular systolic function as assessed by echocardiography; acute-phase
mean EF was 43% ± 8.5% (range 25–51%), and at follow-up mean EF
64.4 +/− 7%, (p = 0.001). This recovery of left ventricular function is
consistentwith the natural history of TTC [16]. 16 patients also received
follow-up CMR at a mean duration of 8 months (range 2-27 months)
after the index event. Ejection fraction had normalized in all cases
(mean EF 43 +/− 10%, follow-up mean 60.2 +/− 7%, p = 0.001). In
all patients with LGE, enhancement fully resolved on follow-up CMR
with normalization of signal intensity and no residual LGE detectable
by quantitative signal analysis.The majority of patients were discharged on medical therapy of an-
giotensin converting enzyme inhibitors, beta-blockers, and aspirin, al-
though there is little evidence to guide clinicians in the effectiveness
of such therapies. One LGE-positive patient received an implantable de-
ﬁbrillator as secondary prevention for resuscitated sudden cardiac
death, and could not therefore undergo a follow-up CMR study.
4. Discussion
Myocardial late gadolinium enhancement (LGE) does occur in the
TTC syndrome, in contrast to initial reports which propose the absence
of LGE as a diagnostic criterion [11]. In this single-centre series, LGE
was conﬁrmed using quantitative signal intensity analysis in 41% of
TTC patients, occurring in a diffuse pattern through the areas ofmyocar-
dial stunning, 89% ofwhichwere N5 SD above normalmyocardium. Late
gadolinium enhancement in TTC may represent diffuse myocyte dam-
age, which would be consistent with the higher serum troponin levels
in the LGE positive group. Thisﬁnding gives some insight into thenature
of myocardial damage occurring in these patients.
4.1. Late gadolinium enhancement (LGE)
The LGE was diffuse in appearance compared to adjacent normal
myocardium. This pattern of LGE differed to that seen in ischemia or
Table 1
Characteristics of patients with TCC, with and without LGE on CMR.
Peak
TnI
μg/L
Sex Age Door-to-MRI
(hours)
RWMA
variant
LVEF
acute
LVEF
f/up
Quantitative
LGE as %LV
mass
N2
SD
N5
SD
LGE
−
ve
1.1 F 83 n/a Apical 28 55 0 0
2.3 F 44 96 Mid 50 57 0 0
0.1 F 82 76 Apical 50 n/a 0 0
0.7 F 69 110 Apical 48 54 0 0
2.2 F 41 47 Mid 40 50 0 0
0.8 F 67 61 Apical 44 56 0 0
1.9 F 87 144 Apical 30 60 0 0
6.4 F 79 n/a Apical 50 n/a 0 0
3.4 F 76 n/a Mid 57 n/a 0 0
4.7 F 46 15 Mid 39 n/a 0 0
3.1 F 57 28 Mid 55 67 0 0
3.2 F 62 92 Mid 42 66 0 0
1.6 F 60 65 Apical 48 66 0 0
4.3 F 76 16 Apical 49 59 0 0
0.2 F 70 46 Apical 44 56 0 0
0.4 F 67 n/a Mid 52 58 0 0
2.4 F 58 45 Apical 35 67 0 0
0.5 F 67 78 Apical 57 n/a 0 0
1 F 69 85 Mid 54 69 0 0
n/a F 66 73 Apical 46 51 0 0
5.5 F 66 76 Apical 28 55 0 0
3 F 70 108 Mid 55 59 0 0
1.6 F 63 6 Apical 36 59 0 0
3.9 F 65 44 Mid 38 54 0 0
6.4 M 64 115 Mid 47 n/a 0 0
2.6 M 71 53 Mid 53 n/a 0 0
LGE
+
ve
0.2 F 67 33 Apical 33 n/a 35.15 0
1.5 F 59 86 Apical 43 19.27 0
1.7 F 76 37 Apical 51 25.01 3.54
7.5 F 63 63 Apical 32 62 30.62 11.43
3.9 F 60 n/a Apical 25 n/a 32.65 11.62
3.5 F 68 27 Mid 36 58 34.8 24
0.2 M 63 115 Apical 45 52 36.6 24.3
0.7 F 62 15 Apical 48 67 24.42 24.47
30 F 68 43 Apical 36 43 46 24.6
1.2 F 63 48 Mid 50 64 46.9 28.75
1.2 F 70 8 Apical 38 69 48.61 29.98
3 F 83 76 Api 45 67 24.3 10.1
2.6 F 73 42 Api 38 n/a 18.4 4.5
3.1 F 66 50 Mid 40 56 11.2 3.3
0.2 M 77 22 Api 38 n/a 29.3 3
4.4 F 76 10 Api 35 69 13.9 1.5
4.3 F 60 17 mid 49 n/a 18 14.4
10 F 50 71 Api 44 53 22.4 7.2
F = female; M = male; TnI = troponin I; RWMA= Regional wall motion abnormality;
LVEF= left ventricular ejection fraction by CMR; f/up= follow up; LGE=− late gadolin-
ium enhancement; SD = standard deviation.
Fig. 4. Bargraph comparing the troponin levels of TTC patients with and without LGE.
Fig. 5. Bargraph comparing LVEF between TTC patients with and without LGE.
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enhancement whereas myocarditis produces midwall or sub-
epicardial enhancement. In TTC the LGE appears to occur in a segmental
distribution associated with abnormal wall motion, and resolves with
time. The pathophysiology of myocardial LGE results from the inherent
relative differences in the volumeof distribution of gadoliniumbetween
normal and abnormal myocardium [17,18]. The distribution of gadolin-
ium is conﬁned to the extracellular and interstitial space, i.e. it does not
penetrate intact myocardial cell membranes. In the normal myocar-
dium, the interstitial space constitutes about 15% of the totalmyocardial
volume. Changes to the interstitium, such as oedema or inﬁltration, in-
crease the volume of distribution allowing a larger amount of gadolin-
ium to penetrate into the tissue. Myocyte necrosis results in loss of
cell membrane integrity, and allows intracellular accumulation of gado-
liniumwhich explains the LGE seen inmyocardial infarction [14,19–21].
Rolf et al. reported 15 patients with TTC using serial endomyocardial
biopsy correlated with CMR imaging to explore the differences in the
extent of oedema, necrosis, and ﬁbrosis [18]. In that report LGE was
assessed dichotomously as either present or absent, but the degree of
LGE was not quantiﬁed. Immunohistochemical analysis of
endomyocardial biopsies was reported to show disorganization of con-
tractile and cytoskeletal proteins, elevated extracellular matrix, but not
cell death. The authors concluded that the diffuse LGE pattern seen their
study resulted from expansion of extracellularmatrix and acute ﬁbrosis,
rather than due to cell necrosis or oedema. In the present study, how-
ever, the trend to higher mean TnI values in patients with diffuse LGE
implies a greater degree of myocyte disruption or death in those pa-
tients. Troponin is speciﬁc for myocardial cell damage, and any posi-
tively detectable circulating serum troponin (N99th percentile upper
limit of normal) reﬂects microscopic zones of myocardial necrosis, as
deﬁned in the ESC/ACCF/AHA/WHF task force deﬁnition. The positive
troponin in these patients suggests myocyte damage is occurring, possi-
bly in a diffuse manner within the affected area of myocardial stunning.
A larger sample cohort would be required to test the validity of this
observation.
It should benoted, also, that endomyocardial biopsy as performed by
Rolf et al. targets the sub-endocardiumwith limitedpenetration into the
myocardium, and the diffuse pattern of LGE seen in the present study
was not subendocardial in nature. It is possible, therefore, that
endomyocardial biopsy may not have detected regions of mid-wall
myocyte necrosis, or that other factors may be involved in the mecha-
nism of diffuse LGE. To further clarify this issue, an autopsy case with
a prior in-vivo CMR would be required to further correlate the true na-
ture of LGE in TTC; much as demonstrated by Moon et al. for hypertro-
phic cardiomyopathy in which the histological basis for LGE for that
condition was deﬁned [22]. Partial or complete resolution of LGE over
time has been well documented in myocarditis [15,23,24], the mecha-
nism of which is not entirely understood. The same appears to be true
73N. Gaikwad et al. / IJC Heart & Vasculature 12 (2016) 68–74for LGE in the Tako-tsubo cardiomyopathy, in which LGEmay be aman-
ifestation of multiple factors including cellulary injury, oedema, ex-
panded extracellular matrix and acute ﬁbrosis.
The present results suggest that absence of LGE should not be a de-
ﬁning criterion for TTC, in contrast to previous reports [8,11,16,24].
LGE signal intensity of up to 3 SD has been reported previously [25], in-
cluding in midwall-variant TTC [9,10].
In our study, however, LGEwas observed at increased signal intensi-
ties N5 SD using identicalmethods and software as previous studies.We
postulate two reasons for the increase in LGE in our study. Firstly our co-
hort had scans early in the acute phase, and secondly the dose of gado-
linium in our protocol is higher as compared to the above study
(0.2 mmol/kg vs 0.1 mmol/kg). It is unclear from this small observa-
tional studywhether presence of LGE confers aworse prognosiswith al-
tered myocardial recovery or greater a propensity for recurrence. There
was however no difference in follow-up LV function as assessed by
echocardiography or CMR in this group.
4.2. Wall motion
We noted that the LGE was pronounced in the area of wall motion
abnormality. The mid-wall variant formed 45% of this patient cohort,
which is similar to previous reports [8,26]. There was no signiﬁcant dif-
ference in ejection fraction, or propensity for diffuse LGE, between the
mid-wall and apical variants; but the study was not statistically
powered to detect such a difference. The patient with resuscitated sud-
den cardiac death also exhibited right ventricular involvement, as man-
ifested by dyskinesia of the right ventricular free wall, resolving on
follow-up imaging. Right ventricular involvement has been reported
to be associated with a more severe clinical manifestation including
acutely decompensated heart failure or shock [11]. There is debate as
to the relevance of various wall motion defects in TTC, which simply
may represent partial recovery of some segments. Recently, opinion-
leaders stated that “subclassifying and renaming this cardiomyopathy
according to speciﬁc LV contraction patterns could lead to more confu-
sion” [1]. These authors recommended researchers categorize the di-
verse forms of wall motion abnormalities under the broad term of
“Tako-tsubo cardiomyopathy”.
[17].
We believe this is an accurate, quantitative and carefully-performed
study which has highlighted subtle but deﬁnite changes in myocardial
tissue characterization, detected as a result of MRI very early in the clin-
ical course of Tako-tsubo patients (short door-to-MRI time, allowing de-
tection of diffuse LGE signal in these patients). This novel observation
adds to our understanding of the pathophysiology in Tako-tsubo
cardiomyopathy.
5. Conclusion
Late gadolinium enhancement does occur in the Tako-tsubo cardio-
myopathy syndrome, in a diffusemanner, with signal intensity N5 SD in
some patients. The pattern of LGE is different to that seen in ischemia,
myocarditis, or inﬁltrative disorders of the myocardium. LGE occurs in
the affected area ofmyocardial stunning. “Absence of LGE” per se cannot
therefore be used as a criterion for the diagnosis of TTC. Further collab-
orative multi centre studies, with agreement on imaging protocols, as-
sessment of perfusion, follow-up timing and core-lab interpretation of
CMR images and LGE quantiﬁcation, coupled with biomarker and im-
munohistochemical analyses, are required to further deﬁne the natural
history and aetiology of this disorder and of the pathophysiology under-
ling CMR enhancement patterns. [18].
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